logo
Select company
Select metric
11.41%Debt to Assets Ratio
VS
Market
62
Sector
53
Industry
40
History
5
$ 27.98Close
$ 6.28 - $ 27.98 52-Week Range
Ticker Information

Ticker

NTLA

Company Name

INTELLIA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

INTELLIA THERAPEUTICS INC - Debt to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NTLA - Debt to Assets Historical data
DateTotal AssetsTotal DebtDebt to Assets Ratio
6/30/2025$ 898.89M$ 102.59M11.41%
3/31/2025$ 986.16M$ 119.25M12.09%
12/31/2024$ 1.19B$ 210.2M17.65%
9/30/2024$ 1.17B$ 101.62M8.66%
6/30/2024$ 1.19B$ 106.3M8.92%
3/31/2024$ 1.26B$ 110.86M8.8%
12/31/2023$ 1.3B$ 115.35M8.87%
9/30/2023$ 1.24B$ 118.34M9.52%
6/30/2023$ 1.32B$ 122.33M9.24%
3/31/2023$ 1.42B$ 126.13M8.9%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INTELLIA THERAPEUTICS INC's latest trailing twelve months (TTM) Debt to Assets stands at 4.84%.
  • Over the past 5 years, INTELLIA THERAPEUTICS INC's average Debt to Assets has been 8.83%.
  • The median Debt to Assets for INTELLIA THERAPEUTICS INC during this period was 8.88%
  • INTELLIA THERAPEUTICS INC reached its highest Debt to Assets over the past 5 years at 17.65%.
  • The lowest Debt to Assets recorded by INTELLIA THERAPEUTICS INC in the same timeframe 4.84%

INTELLIA THERAPEUTICS INC's Debt to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Debt to Assets Benchmarks
CompanyDebt to Assets
ABCL : ABCELLERA BIOLOGICS INC 9.78%EYPT : EYEPOINT PHARMACEUTICALS INC 7.24%ZVRA : ZEVRA THERAPEUTICS INC 24.3%BEAM : BEAM THERAPEUTICS INC 11.13%MGTX : MEIRAGTX HOLDINGS PLC 40.49%SNDX : SYNDAX PHARMACEUTICALS INC 57.96%LXRX : LEXICON PHARMACEUTICALS INC 24.87%OCUL : OCULAR THERAPEUTIX INC 17.05%WVE : WAVE LIFE SCIENCES LTD 8.6%SCPH : SCPHARMACEUTICALS INC 101.43%

Definition of Debt to Assets Ratio

[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Debt / Assets
(=) Debt to Assets
Debt to Assets for INTELLIA THERAPEUTICS INC is calculated as follows: Debt [ $ 22.2M ] / Assets [ $ 458.56M ]
(=) Debt to Assets [ 4.84% ]

NTLA - Debt to Assets Ratio, Last 5 years

4.84%

Minimum

Sep 30, 2020

17.65%

Maximum

Dec 31, 2024

8.83%

Average

8.88%

Median

Debt to Assets Benchmark Analysis

The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.32% with a standard deviation of 24.51%.
The following table provides additional summary stats:
Debt to Assets in the Market:
filtered constituents4.38K
min0%
max116.6%
average26.32%
median21.04%
std24.51%